Swiss Medendi SA

medical devices

About

Founded in December 2012, Swiss Medendi SA developed a proprietary technology for the intravenous (IV) administration of vesicant and irritant drugs. This technology permits a safe chemotherapy infusion via peripheral venous access devices, therefore it protects the patient's blood vessels from chemical phlebitis and increases the patient's quality of life. This technology further creates significant cost saving to hospitals and other medical providers. The Swiss Medendi solution offers the safest and most cost effective means for IV infusion of vesicant and irritant drugs minimizing adverse side effects, risks and injuries. Further it results in providing better treatment to the patient by eliminating unnecessary procedures, such as placement of central line (CL) supporting catheter reducing initiatives when the risks exceed their benefits.

Technologies

Mobile Friendly Apache WordPress.org Google Font API

Keywords

medical equipment manufacturing patient care services patented technology medical device for oncology medical device patents polymer-based antimicrobial solutions corrosion inhibitor polymers medical device for cancer therapy medical devices chemical injury reduction personal care polymers vesicant drug delivery chemical phlebitis prevention infusion technology medical device innovation metal conservation polymers b2b corrosion protection polymers non-invasive devices vesicant and irritant drug delivery antimicrobial polymers healthcare medical device for pathologies medical device manufacturing ce certified safety and risk reduction food grade polymers cost-effective infusion solutions regulatory compliance

Location

24 Via Carlo Maderno, Lugano, Ticino, Switzerland, 6900

Related Companies

Companies in the same industry